<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01185145</url>
  </required_header>
  <id_info>
    <org_study_id>WIRB #20040075</org_study_id>
    <nct_id>NCT01185145</nct_id>
  </id_info>
  <brief_title>Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy</brief_title>
  <acronym>APBI</acronym>
  <official_title>A Phase II Study of Accelerated Partial Breast Radiotherapy With Either a Novel Breast Brachytherapy Technique - Mammosite or Intensity Modulated Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rocky Mountain Cancer Centers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Charles Leonard, MD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rocky Mountain Cancer Centers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Accelerated Partial Breast Irradiation by Mammosite and intensity modulated radiotherapy is
      safe and effective in patients with early stage breast cancer resected by lumpectomy.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2004</start_date>
  <completion_date type="Anticipated">August 2024</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>2-15 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease free survival</measure>
    <time_frame>2-15 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cause specific survival</measure>
    <time_frame>2-15 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ipsilateral breast failure</measure>
    <time_frame>2-15 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serious Adverse device-related Events</measure>
    <time_frame>2-5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">291</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Mammosite</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Accelerated Partial Breast Irradiation using Mammosite RTS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IMRT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Accelerated partial breast irradiation using IMRT planning technique of external beam radiotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Breast Brachytherapy with Mammosite RTS</intervention_name>
    <description>Treatment will be performed using high dose rate brachytherapy, starting between 2-5 days of implant, 34 Gy at 1 cm in 3.4 Gy fractions BID for 5 treatment days with typical boost dose od 10 Gy given in 2 fractions at least 6 hours apart.</description>
    <arm_group_label>Mammosite</arm_group_label>
    <other_name>Mammosite</other_name>
    <other_name>Breast Brachytherapy</other_name>
    <other_name>Accelerated Partial Breast Irradiation</other_name>
    <other_name>APBI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Intensity Modulated Radiotherapy</intervention_name>
    <description>Accelerated Partial Breast Irradiation using intensity modulated radiotherapy, a novel planning and delivery technique for external beam radiation</description>
    <arm_group_label>IMRT</arm_group_label>
    <other_name>IMRT</other_name>
    <other_name>APBI</other_name>
    <other_name>EBRT</other_name>
    <other_name>Accelerated Partial Breast Irradiation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be a Tis, T1, N0, M0 AJC Classification

          -  Have negative surgical margins (&gt; or = 2 mm) after final surgery

          -  Should have adequate skin spacing between balloon surface and surface the skin (&gt; 7
             mm)*

          -  Patients with infiltrating lobular histologies should have breast MRI scanning as part
             of the initial staging to verify localized T1, or Tis disease

          -  Multifocal findings (define as 2 or more breast quadrants) on MRI scanning should be
             further evaluated by ultrasound and, if necessary biopsy, to exclude multiquadrant
             disease.

        Exclusion Criteria:

          -  Be pregnant or breast-feeding

          -  Have collagen-vascular disease

          -  Inadequate surgical margins (&lt; 2 mm)

          -  Patients with malignant/suspicious calcifications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dennis Carter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rocky Mountain Cancer Centers</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rocky Mountain Cancer Centers - Aurora</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Cancer Centers - Boulder</name>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <zip>80303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Cancer Centers - Midtown</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Cancer Centers - Littleton</name>
      <address>
        <city>Littleton</city>
        <state>Colorado</state>
        <zip>80120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Cancer Centers - Sky Ridge</name>
      <address>
        <city>Lone Tree</city>
        <state>Colorado</state>
        <zip>80124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Cancer Centers - Thornton</name>
      <address>
        <city>Thornton</city>
        <state>Colorado</state>
        <zip>80260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Leonard CE, Tallhamer M, Johnson T, Hunter K, Howell K, Kercher J, Widener J, Kaske T, Paul D, Sedlacek S, Carter DL. Clinical experience with image-guided radiotherapy in an accelerated partial breast intensity-modulated radiotherapy protocol. Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):528-34. doi: 10.1016/j.ijrobp.2009.02.001. Epub 2009 May 19.</citation>
    <PMID>19467799</PMID>
  </reference>
  <reference>
    <citation>Rusthoven KE, Carter DL, Howell K, Kercher JM, Henkenberns P, Hunter KL, Leonard CE. Accelerated partial-breast intensity-modulated radiotherapy results in improved dose distribution when compared with three-dimensional treatment-planning techniques. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):296-302.</citation>
    <PMID>18086392</PMID>
  </reference>
  <results_reference>
    <citation>Lei RY, Leonard CE, Howell KT, Henkenberns PL, Johnson TK, Hobart TL, Fryman SP, Kercher JM, Widner JL, Kaske T, Carter DL. Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT). Breast Cancer Res Treat. 2013 Jul;140(1):119-33. doi: 10.1007/s10549-013-2623-x. Epub 2013 Jul 4.</citation>
    <PMID>23824363</PMID>
  </results_reference>
  <results_reference>
    <citation>Leonard CE, Johnson T, Tallhamer M, Howell K, Kercher J, Kaske T, Barke L, Sedlacek S, Hobart T, Carter DL. Accelerated partial breast intensity-modulated radiotherapy in women who have prior breast augmentation. Clin Breast Cancer. 2011 Jun;11(3):184-90. doi: 10.1016/j.clbc.2011.03.016. Epub 2011 May 4.</citation>
    <PMID>21665139</PMID>
  </results_reference>
  <results_reference>
    <citation>Reeder R, Carter DL, Howell K, Henkenberns P, Tallhamer M, Johnson T, Kercher J, Widner J, Kaske T, Paul D, Sedlacek S, Leonard CE. Predictors for clinical outcomes after accelerated partial breast intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):92-7. doi: 10.1016/j.ijrobp.2008.06.1917. Epub 2008 Sep 9.</citation>
    <PMID>18786783</PMID>
  </results_reference>
  <results_reference>
    <citation>Leonard C, Carter D, Kercher J, Howell K, Henkenberns P, Tallhamer M, Cornish P, Hunter K, Kondrat J. Prospective trial of accelerated partial breast intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1291-8. Epub 2007 Jan 17.</citation>
    <PMID>17234359</PMID>
  </results_reference>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2010</study_first_submitted>
  <study_first_submitted_qc>August 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2010</study_first_posted>
  <last_update_submitted>July 10, 2013</last_update_submitted>
  <last_update_submitted_qc>July 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 11, 2013</last_update_posted>
  <responsible_party>
    <name_title>Dennis Carter, MD, Principle Investigator</name_title>
    <organization>Rocky Mountain Cancer Centers</organization>
  </responsible_party>
  <keyword>breast-conservation</keyword>
  <keyword>accelerated partial breast irradiation</keyword>
  <keyword>APBI</keyword>
  <keyword>IMRT</keyword>
  <keyword>Intensity modulated radiotherapy</keyword>
  <keyword>breast brachytherapy</keyword>
  <keyword>lumpectomy</keyword>
  <keyword>early stage breast cancer</keyword>
  <keyword>DCIS</keyword>
  <keyword>Mammosite</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

